BioLife Solutions, Inc.BLFSNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank36
5Y CAGR-26.8%
Year-over-Year Change
Year-over-year SG&A expense growth
5Y CAGR
-26.8%/yr
Long-term compound
Percentile
P36
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 10.41% |
| 2024 | -10.40% |
| 2023 | 24.59% |
| 2022 | -6.58% |
| 2021 | 128.80% |
| 2020 | 49.58% |
| 2019 | 64.07% |
| 2018 | 29.60% |
| 2017 | -13.05% |
| 2016 | 1.99% |